Briakinumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Briakinumab" in English language version.

refsWebsite
Global rank English rank
1st place
1st place
5,225th place
4,062nd place
low place
low place
low place
low place
2nd place
2nd place
4th place
4th place
11th place
8th place
low place
low place
518th place
331st place

abbott.com

clinicaltrials.gov

  • Clinical trial number NCT00570986 for "A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis" at ClinicalTrials.gov
  • Clinical trial number NCT00691964 for "Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis" at ClinicalTrials.gov
  • Clinical trial number NCT00086671 for "Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)" at ClinicalTrials.gov
  • Clinical trial number NCT00562887 for "Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease" at ClinicalTrials.gov

doi.org

medimmune.com

nih.gov

pubmed.ncbi.nlm.nih.gov

pharmatimes.com

  • "Abbott withdraws briakinumab applications in USA, Europe". PharmaTimes. 17 January 2011. Archived from the original on 17 April 2011.

semanticscholar.org

api.semanticscholar.org

thefreelibrary.com

web.archive.org

  • "Abbott withdraws briakinumab applications in USA, Europe". PharmaTimes. 17 January 2011. Archived from the original on 17 April 2011.
  • "Abbott 2007 Annual Report: Pharmaceuticals". Abbott.com. Archived from the original on 2010-07-31. Retrieved 2010-05-12.
  • "MedImmune: External R&D Partnering". Archived from the original on 2013-04-28. Retrieved 2010-11-21.
  • Abbott Press Release: Abbott Reports Psoriasis Phase III Results of its Investigational IL-12/23 Inhibitor Briakinumab (ABT-874) Archived November 24, 2010, at the Wayback Machine
  • "The Free Library: Cambridge Antibody Technology and Abbott Agree Regarding Royalties". Archived from the original on 2012-10-21. Retrieved 2010-11-21.